FDA approved Novo Nordisk’s injection for obesity
On Dec. 23, 2014, Novo Nordisk the FDA approved a formulation of Novo Nordiskﾒs diabetes drug, liraglutide, for…
Juno Theraputics completed its IPO
On Dec. 23, 2014, Juno Therapeutics announced the closing of its initial public offering of 12.7 million shares…
FDA announced approval of peramivir (Rapivab) for treatment of uncomplicated influenza in adults
On Dec. 22, 2014, Sanofi Pasteur announced the FDA had approved the supplemental biologics license application (sBLA) for…
BioCryst’s RAPIVAB(TM) (peramivir injection) received FDA approval for treatment of influenza in adults
On Dec. 22, 2014, BioCryst Pharmaceuticals announced the FDA had approved RAPIVAB (peramivir injection), an intravenous (i.v.) neuraminidase…
UNMC macular degeneration, regenerative medicine research bolstered by $1.3 million gift
On Dec. 18, 2014, the University of Nebraska Medical Center announced it had received a $1.3 million gift…
FDA approved the use of Gardasil 9 HPV vaccine in the US
On Dec. 11, 2014, Merck announced that the FDA had approved GARDASILﾮ9 (Human Papillomavirus 9-valent Vaccine, Recombinant), Merckﾒs…
FDA approved quadrivalent formulation of Fluzone Intradermal inactivated influenza vaccine
On Dec. 12, 2014, Sanofi Pasteur announced the FDA had approved the supplemental biologics license application (sBLA) for…
University of Minnesota mourned loss of Lee Wattenberg, MD, recognized as the ‘father of chemoprevention’
On Dec. 11, 2014, University of Minnesota mourned loss of Lee Wattenberg, M.D., recognized as the ‘father of…
map of genomic and proteomic pathways created by Project Grandiose
On Dec. 10, 2014, Dr. Andras Nagy, from the University of Toronto and leader of Project Grandiose, announced…
BIO honored Debbie Yaver with inaugural Rosalind Franklin Award
On Dec. 9, 2014, the Biotechnology Industry Organization (BIO) announced that Debbie Yaver, Novozymes’ director of expression technology,…
Philanthropist Paul G Allen founded the Allen Institute for Cell Science with $100 million
On Dec. 8, 2014, philanthropist and entrepreneur Paul G. Allen announced a commitment of $100 million to create…
The Fred & Pamela Buffett Cancer Center announced recruitment of five leading cancer researchers
On Dec. 3, 2014, the Fred & Pamela Buffett Cancer Center at the University of Nebraska Medical Center…
The North Carolina Eshelman School of Pharmacy received $100 million donation from Fred Eshelman
On Dec. 3, 2014, Fred Eshelman, CEO and founder of Wilmington-based PPD Inc. and a member of the…
Whole-genome sequences of 16 different mosquito species published in Science
On Nov. 27, 2014, two papers were published in Science that announced the completion and preliminary analyses of…
Funding was announced for the TEC Health Accelerator for Alberta, to assist promising startup healthcare companies
On Nov. 21, 2014, funding was announced for the TEC Health Accelerator for Alberta, to assist promising startup…
Ford Family Foundation awarded $5 million grant to advance the OHSU Knight Cancer Institute’s rural outreach
On Nov. 5, 2014, the Ford Family Foundation announced a $5 million grant to the Knight Cancer Institute…
FDA approved the use of Trumenba in the US to prevent serogroup B meningococcal disease
On Oct. 29, 2014, Pfizer announced the FDA has granted accelerated approval of TRUMENBAﾮ (meningococcal group B vaccine)…
Biotechnology | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
Philanthropist Paul G Allen donated $100 million to fight Ebola
On Oct. 23, 2014, philanthropist Paul G. Allen donated $100 million to fight Ebola and called on the…
The Jackson Laboratory announced a $10 million gift from David and Barbara Roux
On Oct. 21, 2014, The Jackson Laboratory (JAX) announced that technology investor David Roux and his wife Barbara…
OHSU, partners Kineta, U of Washington, VGTI Florida awarded $10 million NIH contract to develop new vaccine adjuvants
On Oct. 20, 2014, Oregon Health & Science University’s Vaccine & Gene Therapy Institute (OHSU) announced it was…
Genentech drug Esbriet (pirfenidone) was approved
On Oct. 15, 2014, Genentech drug Esbriet (pirfenidone) was approved by the U.S. Food and Drug Administration (FDA)…
The University of Iowa dedicated $126 million biomedical hub
On Oct. 15, 2014, the University of Iowa ushered in a new age of accelerated research in biomedicine…
The annual World Thrombosis Day was launched
On Oct. 13, 2014, the International Society on Thrombosis and Haemostasis launched the annual World Thrombosis Day World…
Biotechnology | Diagnostics | Disease | Life Science News | Medical Device | Medicine | Non-Profit Research | Therapeutics
The University of Minnesota’s Children’s Hospital was renamed the University of Minnesota Masonic Children’s Hospital
On Oct. 13, 2014, the University of Minnesota’s Children’s Hospital was renamed the University of Minnesota Masonic Children’s…
Nebraska Medical Center, Bellevue Medical Center and UNMC Physicians renamed Nebraska Medicine
On Oct. 13, 2014, the Nebraska Medical Center, Bellevue Medical Center and UNMC Physicians – once three separate…
OSU, Cardinal Health, State of Ohio complete $13 million advance medical imaging facility
On Oct. 8, 2014, Ohio State University, Cardinal Health and State of Ohio Third Frontier Commission announced completion…
May-Britt Moser won a share of the Nobel Prize in Physiology or Medicine for helping discover cells that constitute a positioning system in the brain.
On Oct. 6, 2014, May-Britt Moser won a share of the 2014 Nobel Prize in Physiology or Medicine…
Becton, Dickinson acquired CareFusion for $122 billion
On Oct. 5, 2014, BD and CareFusion announced a definitive agreement whereby BD acquired CareFusion for $58.00 per…
Canadian diamond pioneer Charles Fipke donated $9.1 million for Alzheimer’s research at UBC
On Sept. 30, 2014, Canadian diamond pioneer Charles Fipke donated $9.1 million for Alzheimer’s research at the University…
David H Murdock announced endowment for DHMRI
On Sept. 30, 2014, David H. Murdock, owner and chair of Castle & Cooke, and builder and founder…